Lexicon Genetics Wins Additional US Patent for Gene Targeting
Feb 12, 2004
NEW YORK, Feb. 12 (GenomeWeb News) - Lexicon Genetics has won a USpatent that "broadly covers" a technology used in gene targeting for its gene-knockout technology, the company said today.
U.S.Patent No. 6,689,610 comprises "a variety of methods" of selecting certain gene manipulations made by gene targeting, Lexicon said. It said the patent also covers methods called "positive- positive" selection.
In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.
Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.
With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.